Pace J, Bertasso A, Georgopapadakou N H
Roche Research Center, Hoffmann-La Roche, Inc., Nutley, New Jersey 07110-1199.
Antimicrob Agents Chemother. 1991 May;35(5):910-5. doi: 10.1128/AAC.35.5.910.
Ro 23-9424 is a broad-spectrum antibacterial agent consisting of a cephalosporin (desacetylcefotaxime) linked through an ester bond to a fluoroquinolone (fleroxacin). Its activity against mutants of Escherichia coli TE18 resistant to both antibacterial components was examined. E. coli TE18 overproduces the AmpC beta-lactamase and is resistant to several cephalosporins, including desacetylcefotaxime (MIC, 50 micrograms/ml), although it is still susceptible to Ro 23-9424 (MIC, 0.2 microgram/ml). Thirty-five spontaneous, two-step mutants of E. coli TE18 which were resistant to fleroxacin (MIC, 50 micrograms/ml) were isolated. In the mutants, replicative DNA biosynthesis (permeabilized cells) was resistant to fleroxacin, and some mutants had porin abnormalities. However, all remained susceptible to Ro 23-9424 (MIC, 0.5 microgram/ml). Examination of beta-lactamase activity in the parent strain revealed that it hydrolyzes desacetylcefotaxime more rapidly than it does Ro 23-9424. Thus, Ro 23-9424 may be less susceptible to the gram-negative, chromosomal beta-lactamases that hydrolyze several broad-spectrum cephalosporins and may be effective in cases in which neither of its two components is active.
Ro 23-9424是一种广谱抗菌剂,由通过酯键与氟喹诺酮(氟罗沙星)相连的头孢菌素(去乙酰头孢噻肟)组成。研究了其对两种抗菌成分均耐药的大肠杆菌TE18突变体的活性。大肠杆菌TE18过量产生AmpCβ-内酰胺酶,对包括去乙酰头孢噻肟(MIC,50微克/毫升)在内的几种头孢菌素耐药,尽管它对Ro 23-9424仍敏感(MIC,0.2微克/毫升)。分离出35株对氟罗沙星耐药(MIC,50微克/毫升)的大肠杆菌TE18自发两步突变体。在这些突变体中,复制性DNA生物合成(透化细胞)对氟罗沙星耐药,一些突变体存在孔蛋白异常。然而,所有突变体对Ro 23-9424仍敏感(MIC,0.5微克/毫升)。对亲本菌株β-内酰胺酶活性的检测表明,它水解去乙酰头孢噻肟的速度比对Ro 23-9424的水解速度更快。因此,Ro 23-9424可能对水解几种广谱头孢菌素的革兰氏阴性染色体β-内酰胺酶不太敏感,并且在其两种成分均无活性的情况下可能有效。